Prof. Wagida A. ANWAR
Prof. Wagida A. Anwar
Professor at Department of Community, Environmental and Occupational Medicine; Faculty of Medicine, Ain Shams University, Egypt
President of PAEMSGS
President of Egyptian Environmental Mutagen Society
President of the Specialized Federation of Scientific Research NGOs, Egypt
She is graduated from Faculty of Medicine, Ain Shams University, Egypt in December 1977. She obtained her training from several institutions in different countries (France, USA, Japan, Germany, Sweden, Canada and Finland). As a General Coordinator of Health System Improvement Programs, Ministry of Health, Egypt since 2014, she contributed in Drafting the Social Health Insurance Law (SHI), National Health Policy and Health component of the Sustainable Development Strategy 2030, which is a continuation of her contribution in Health Sector Reform Program in Egypt (1996-2002). She is the PI of several projects funded from different sources nationally and internationally. Internationally, she is a member of several Committee and Associations including Health Literacy Working Group, WHO Global Coordination Mechanism for The Prevention and Control of NCD (GCM/NCD), WHO since 2016, the Jury of the UNESCO – International Prize for Research in Life Sciences (Since 2009). Collegium Ramazini, Carpi, Italy since 2006. President, Pan African Environmental Mutagen Society (2017). Nationally, she is a member of several Committee at the Ministry of Health, Academy of Science and Technology and the National Women Council. She is the President of the Specialized Federation for Health System Improvement NGOs, since 2014. Professor Anwar received a number of international prizes and awards including Marie Curie, FP7, EC, (2008), Dr. A. T. Shousha Foundation Prize (WHO) for 2001, Fogarty International Fellowship Award, (1986) and the CEES Award, France (1986). Nationally, she received Ain Shams University Honorary Award, 2017, Egyptian National Award of the Academy of Sciences, (1992) and several other awards.
Dr Olawale AJUWON
Dr Olawale Ajuwon is currently a Senior Lecturer and Principal Investigator at the Redox Biology Research Unit, Department of Biochemistry, Federal University, Oye-Ekiti, Nigeria. He completed his Doctorate in Biomedical Technology (2013) at the Oxidative Stress Research Centre, Cape Peninsula University of Technology, South Africa. From 2014 – 2016, he was a Claude Leon Postdoctoral Fellow at the Department of Human Biology, University of Cape Town, South Africa. He was also a Swiss Government Excellence Postdoctoral Scholar between 2016 and 2017 at the Department of Physiology, University of Lausanne, South Africa. The current focus of research in his laboratory is centred on how a better understanding of redox homeostasis in disease conditions could lead to the development of natural bioactive compounds for the treatment of diseases such as cancer and diabetes.
Dr Debasis BAGCHI
Debasis Bagchi, PhD, MACN, CNS, MAIChE, received his Ph.D. in Medicinal Chemistry in 1982. He is the Director of Scientific Affairs, VNI Inc., Lederach, PA; a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy, Houston, TX, and, an Adjunct Faculty in Texas Southern University, Houston, TX. He served as the Chief Scientific Officer at Cepham Inc, Belmont, NJ, from June 2013, till Dec 2018. He served as the Senior Vice President of Research & Development of InterHealth Nutraceuticals Inc, Benicia, CA, from 1998 till Feb 2011, and then as Director of Innovation and Clinical Affairs, of Iovate Health Sciences, Oakville, ON, till June 2013.
Dr. Bagchi received the Master of American College of Nutrition Award in October 2010. He is the Past Chairman of International Society of Nutraceuticals and Functional Foods (ISNFF), Past President of American College of Nutrition, Clearwater, FL, and Past Chair of the Nutraceuticals and Functional Foods Division of Institute of Food Technologists (IFT), Chicago, IL. He is serving as a Distinguished Advisor on the Japanese Institute for Health Food Standards (JIHFS), Tokyo, Japan. Dr. Bagchi is a Member of the Study Section and Peer Review Committee of the National Institutes of Health (NIH), Bethesda, MD. Dr. Bagchi has 360 papers in peer reviewed journals, 39 books and 20 patents. Dr. Bagchi is also a Member of the Society of Toxicology, Member of the New York Academy of Sciences, Fellow of the Nutrition Research Academy, and Member of the TCE stakeholder Committee of the Wright Patterson Air Force Base, OH. Dr. Bagchi is the Associate Editors of the Journal of Functional Foods, Journal of the American College of Nutrition, and Archives of Medical and Biomedical Research, and also serving as Editorial Board Member of numerous peer reviewed journals, including Antioxidants & Redox Signaling, Cancer Letters, Food & Nutrition Research, Toxicology Mechanisms and Methods, The Original Internist, and other peer reviewed journals.
Prof Emmanuel BOURDON
Dr Emmanuel Bourdon completed his PhD in Biochemistry in 2000 at Dijon (France) and has been actively involved in research on the molecular aspects of diabetes and obesity. He completed his research formation by a two years postdoctoral position at National Institutes of Health (Bethesda, USA) and by a one year and a half postdoc in France. In 2004, he got a permanent position as researcher and Professor at the Université de la Réunion (La Réunion, France). Since 2004, Dr Bourdon has lead a working group on interactions between oxidative stress and cellular pathophysiology in diabetes and obesity context. He is the author/co-author of more than 65 publications in that field of research. Also, nine students have supported a doctoral thesis under his direction and two are under progress. He is a regular reviewer for the evaluation of scientific articles subjected to review by a peer. He has developed productive local and international collaborations especially with the local hospital (CHU, La Réunion) and with the groups of Pr. Faadiel Essop (Stellenbosch, South Africa) and Pr. Theeshan Bahorun (Réduit, Maurice).
Five recent significative publications:
Guerin-Dubourg, A., Cournot, M., Planesse, C., Debussche, X., Meilhac, O., Rondeau, P. and Bourdon, E. (2018) “Association between fluorescent Advanced Glycation Endproducts and vascular complications in type 2 diabetic patients” BioMed Research International, vol. 2017, Article ID 7989180
Patche, J., Girard, D., Catan, A., Boyer, F., Dobi, A., Planesse, C., Diotel, N., Guerin-Dubourg, A., Baret, P., Bravo, S.B., Paradela-Dobarro, B., Álvarez, E., Essop, M.F., Meilhac, O., Bourdon, E. (co-dernier auteur) and Rondeau, P. (2017) “Diabetes-induced hepatic oxidative stress in a mouse model: a new pathogenic role for glycated albumin” Free Radic Biol Med 102:133-148
Ramlagan, P., Planesse, C., Rondeau, P., Neergheen-Bhujun, V., Bourdon, E (co-dernier auteur). and Bahorun, T. (2017) “Comparative suppressing effects of black and green teas on the formation of advanced glycation end products (AGEs) and AGE-induced oxidative stress.” Food Funct. 15:4194-4209
Mapanga, R.F., Joseph, D.E., Saieva, M., Boyer, F., Rondeau, P., Bourdon, E. and Essop, M.F. (2017) “Glycation abolishes the cardioprotective effect of albumin during ischemia-reperfusion” Physiol Rep. doi: 10.14814/phy2.13107
Boyer, F., Diotel, N., Girard, D., Essop, M.F., Rondeau and Bourdon, E. (2016) “Enhanced oxidative stress in adipose tissue from diabetic mice, possible contribution of glycated albumin” Biochem Biophys Res Commun. 473:154-60 IF 2.37
Prof Faadiel ESSOP
Prof. Faadiel Essop is currently a professor at the Department of Physiological Sciences at Stellenbosch University (South Africa) and the Director of the newly established Centre for Cardio-metabolic Research Centre in Africa (CARMA) at Stellenbosch University. Prof. Essop completed his under- and postgraduate studies at the University of Cape Town and was later awarded a Fulbright fellowship to further his research at the University of Texas-Houston Medical School (TX, USA). He subsequently moved to Stellenbosch University and established a research group that focuses on the so-called ‘’dual burden of disease’’ (HIV-related cardiovascular diseases and the onset of cardiovascular diseases in the general population) that is threatening developing countries. Prof. Essop is a former chairperson of the Department of Physiological Sciences, a former President of the Physiology Society of Southern Africa (two terms), the current Vice-President of the African Association of Physiological Sciences and a board member of the General Assembly of the International Union of Physiological Sciences. He also served as a member of the International Committee of the American Physiological Society and is an elected Fellow of the American Physiological Society.
Prof Olivier JOUBERT
Associate Professor in toxicology and sanitary safety
December 11th 2015: Certificate for conducting Researches (Habilitation à Diriger les Recherches)
November 23rd 2005: PhD in cellular and molecular aspects of biology
Skills and topics of interest
• Nanotoxicology, toxicogenomic, molecular biology
• Development of in vitro assays to study the interaction cell-
• Cell biology, Biochemistry of membrane proteins, protein’s structure-function studies
Since January 2018: Assistant Professor in toxicology, Lorraine University – UMR 7198 Institut Jean Lamour, Pr B. Rihn Nanoparticles, study of the impact on human cells transcriptomes.
September 1st 2009 – December 31st 2017: Assistant Professor in toxicology, Lorraine University – EA 3452 CITHEFOR
January 2009 – august 2009: Under contract researcher at Commissariat à l’Energie Atomique Saclay (CEA), SIMOPRO.
August 2006 – december 2008: Under contract researcher at FRE CNRS 3094, Nice Sophia-Antipolis University.
October 2002 – november 2005: PhD candidate at physiopathology and antibiology of nosocomial and rising bacterial infections UPRES EA-3432, Strasbourg.
Since 2017: French Agency for Food, Environmental and Occupational Health & Safety (ANSES): Member of the “Assessment of the risks related to air environments” Scientific expert’s committee (CES-AIR)
Member of the working group dedicated to food and nano (GT nanos et alimentation)
Member of the working group dedicated to asbestos and oral route (GT amiante)
Member of the TAIEX expert’s panel, European experts on research and education
Member of the editorial board of “Environnement Risques et Santé” Ed John Libbey
Member of the editorial board of “Nanomaterials” Ed MDPI
2018-2021 Bonus for Scientific Excellence A award (<20% best)
2014-2017 Bonus for Scientific Excellence B award (20-50% best researcher in his discipline)
2016-2020: WP leader in H2020 Smartnanotox project (8M€)
2019-2020: Projet Hubert Curien Protea 42363wk with Pr Oluwafemi Univ. of Johannesbourg, RSA (18k€)
H-index = 15
i10-index = 23
Citations = 770
45 Protein and lipid homeostasis altered in rat macrophages after exposure to metallic oxide nanoparticles.
DOUMANDJI Z, SAFAR R, LOVERA-LEROUX M, NAHLE S, CASSIDY H, MATALLANAS D, RIHN B, FERRARI L, JOUBERT O;
Cell Biology and Toxicology. 2019. doi: 10.1007/s10565-019-09484-6.
IF = 5,097
Metal accumulation, biochemical and behavioral responses on the Mediterranean clams Ruditapes decussatus exposed to two photocatalyst nanocomposites (TiO2 NPs and AuTiO2NPs).
SAIDANI W, SELLAMI B, KHAZRI A, MEZNI A, DELLALI M, JOUBERT O, SHEEHAN D, BEYREM H.
Aquatic Toxicology. 2019 Jan 7;208:71-79.
IF = 3.794
39 Encapsulation of S-nitrosoglutathione: a transcriptomic validation.
SAFAR R, HOULGATTE R, LE FAOU A, RONZANI C, WU W, FERRARI L, DUBOIS-POT-SCHNEIDER H, RIHN BH, JOUBERT O.
Drug Development and Industrial Pharmacy. 2018 Nov 17:1-28.
IF = 2,367
Cytotoxicity and global transcriptional responses induced by zinc oxide nanoparticles NM 110 in PMA-differentiated THP-1 cells.
SAFAR R, DOUMANDJI Z, SAIDOU T, FERRARI L, NAHLE S, RIHN BH, JOUBERT O.
Toxicology Letters. 2018 Nov 10.
31 Elaboration of Sterically Stabilized Cationic and Anionic Liposomes for S-nitrosoglutathione Targeting to Macrophage
R. DIAB, A. S. VIRRIAT, C. RONZANI, S. FONTANAY, S. GRANDEMANGE, A. ELAISSARI, B. FOLIGUET, P. MAINCENT, P. LEROY, R. E. DUVAL, B. H. RIHN, O. JOUBERT
Journal of Biomedical Nanotechnology Volume 12, Number 1, January 2016, pp. 217-230(14)
IF = 3,578
Preservation of the activity of curcumin-loaded PLGA nanoparticles on Akt/Tau phosphorylation with improved neuroprotective, antioxidant and anti-inflammatory activities
G. DJIOKENG PAKA, S. DOGGUI, A. ZAGMI, R. SAFAR, L. DAO, A. KLYMCHENKO, G. ROULLIN, O. JOUBERT, C. RAMASSAMY
Molecular pharmaceutics. 2015 Nov 30. [Epub ahead of print] PMID: 26618861
IF = 4,341
Comment on Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
B.H. RIHN, O. JOUBERT
ACS Nano, 2015, 9 (6), pp 5634–5635 DOI: 10.1021/acsnano.5b00459
IF = 13,334
Human monocyte response to S-nitrosoglutathione-loaded nanoparticles: uptake, viability and transcriptome
R. SAFAR, C. RONZANI, R DIAB, J. CHEVRIER, S. GRANDEMANGE, D. BENSOUSSAN, A LE FAOU, B. RIHN, O. JOUBERT
Molecular pharmaceutics 2015 Jan 14. PMID: 25536094
IF = 4,341
Long term magnesium deficiency increases mortality through effects on inflammation parameters and oxidant stress defense in AGEING rats.
D. BLACHE, S. DEVAUX, O. JOUBERT, N. LOREAU, M. SCHNEIDER, P. DURAND, M. PROST, V. GAUME, M. ADRIAN, P. LAURANT, A. BERTHELOT.
Free Radical Biology and Medicine, 2006 Jul 15;41(2):277-84.
Prof Wentzel CA GELDERBLOM
Prof Gelderblom obtained his PhD and DSc degree at the University of Stellenbosch in 1986 and 2009, respectively. He received a postdoctoral fellowship from the MRC during 1988 and spent one year in the Department Pathology of the Toronto University under the guidance of Prof E Farber, a world authority on rat liver carcinogenesis after which he established the sub programme in Experimental Carcinogenesis. During 1996 he spent one year at the International Agency for Research on Cancer (IARC) after receiving the Visiting Scientist Award for his research on the mechanisms of cancer induction of the fumonisins, fungal toxins. He served on international research Working groups of the WHO (JECFA) and IARC on the evaluation of risk parameters and carcinogenesis potency of the fumonisin B mycotoxins during 2001. Being invited as plenary speaker or chairperson to many research conferences on fumonisins organised by the FDA and the Gordon Research Conference. He performed ground breaking research on the cancer preventive properties of South African herbal teas and dietary fatty acids and obtained research funding form the South African Rooibos Council, the Cancer Association of South Africa and the National Research Foundation. The competence and research standing in the field of chemical carcinogenesis are evidenced from the following:
• sustained a record of publishing in leading general scientific journals (Carcinogenesis, Cancer Letters, Nature Medicine, Mutation Research, Food and Chemical Toxicology, Toxicology and J Agric and Food Chem.);
• recognised international research standing for the discovery of the fumonisin B mycotoxins that are responsible for many animal diseases and implicated in certain human cancers (oesophagus and liver).
• Research has been highlighted in popular science articles as reflected by the high science citation index (up to 400 to 900) of some papers.
• established strong collaborative links with several national and internationally scientists in his field. Instrumental in establishing the Biomedical and Microbial Institute in Biotechnology at the Cape Peninsula University of Technology as Research Chair.
• B1 rated Scientist with an H index of approx 50 (Scopus)
Current position: Extraordinary professor, Department of Biochemistry Stellenbosch University, South Africa.
Scientific Publications: 141
Books/Chapters in Books: 16
National Conferences: 157
International Conferences: 198
Post graduate training: 21 (8 x PhD)
Prof Kensese S. MOSSANDA
Prof KSA Mossanda holds a degree in Pharmacy; 3 Master’s degrees in: Tropical Medicine & Biology, Clinical Biology and Food sciences and a PhD in Pharmaceutical Sciences (Biochemistry & Toxicology) from the State University of Liege, Belgium. His previous appointments include: Postdoctoral Fellow in many Universities in Europe, USA, Asia and Africa; Professor, Dean of Faculty of Pharmacy, and Head of Clinical Biology Department at the University of Kinshasa, DR-Congo. As Professor and Research Coordinator at Medical University of Southern Africa (Medunsa) and also at Walter Sisulu University (WSU-South Africa), he has been teaching Clinical Biochemistry and Toxicology and leading clinical research projects. He is presently conducting research projects in Canada and supervising of postgraduate students from African and Western Institutions especially in the fields of Cancer, Medicinal plants and Natural products. He is also acting as external examiner of Masters and PhD dissertations from various academic Institutions.
His research expertise includes: Biochemistry, Toxicology, Carcinogenesis, Mutagenesis, Traditional Medicine, Chemoprevention and Anti-inflammatory activities of medicinal plants, He has published 75 papers in peer-reviewed journals and refereed/peer-reviewed conference proceedings, 3 chapters in book and 1 book.
Prof David PHILLIPS
David Phillips is Professor of Environmental Carcinogenesis at King’s College London. Prior to joining King’s in 2011 he was for many years at the Institute of Cancer Research, after post-doctoral fellowships in the USA (Univ. Wisconsin and Stanford Univ.). His research interests are in environmental causes of cancer and in mechanisms of carcinogenesis, in particular the formation and biological consequences of DNA adducts. Current research is focused on the mutational signatures formed in vitro by environmental carcinogens and on relating these to mutational patterns found in human tumours. He is Past President of the UK Environmental Mutagen Society, was formerly Chair of the UK government advisory Committee on Carcinogenicity and previously editor-in-chief of the journal Mutagenesis.
Prof Henrik E POULSEN
1. Personal Info
Henrik Enghusen Poulsen, Birkevænget 4, 3050 Humlebæk
Medical Doctor, Faculty of Health Sciences, University of Copenhagen, January 1976. License to independent medical practice 1979. Dr. Sci. University of Copenhagen, 1986. Licensed Specialist in Clinical Pharmacology May 1997.
3. Present position
August 1996 – 2009. Professor, Chair in Clinical Pharmacology, Rigshospitalet, Copenhagen. 2009 – present. Same position at Department of Clinical Pharmacology, Bispebjerg Frederiksberg Hospital, Institute of Clinical Medicine, Health Science Faculty, Univ. of Copenhagen (Merger, formation of The Capital Region of Copenhagen)
1994 The Danin Award
2018 The Society for Free Radical Research-Europe SFRR Europe Clinical Science Award
5. Scientific focus
Scientific focus areas are Oxidative stress and RNA oxidation (mainly Type 2 Diabetes). Oxidative stress – focus on translational aspects. Several large epidemiological studies and intervention studies have been completed and published, focusing on diabetes type-2 and severe mental disease. Oxidative RNA modification in vivo.
6. International relations
International relations SFRR-Europe, EU-COST Actions COST Actions 16112, COST Actions 16113, international collaborations (USA, Germany, Spain)
Primary supervisor of 18 PhD. students, co-supervisor of a large number ofl PhD students, 14 master students (biochemistry, pharmacology, medicine, human biology, chemistry, pharmacy)
Chairman of the MD PhD program (about 450 PhD students), member of the executive faculty committee and the steering Board of the Faculty of Health Sciences. (1990 – 95)
8. Other activities
Chairman of the Committee for Environmental Medicine in an Institute of Public Health at the University of Copenhagen and member of the Co-ordinating Committee for establishing an Institute of Public Health, University of Copenhagen. Representative for Rigshospitalet in the Central Drug Committee of Copenhagen and chairman of The Drug Committee of Rigshospitalet. Chariman of the board of Danish Society of Clinical Pharmacology (1997-2001). President Society for Free Radical Research Europe Editorial Committee member Society for Free Radical Research – International Society for Free Radical Research.
Bibliometric summary (Scopus): Publication list 407 Citation count 16901, H-index 67. Highest citation counts: 769, 580, 551, 488, 376 .
10. Link to complete list of publications or ORCID number
www.enghusen.dk pubmed search Poulsen HE, Scopus Search Poulsen H.E.
ORCID ID 0000-0003-4242-9924
Prof Vidushi Shradha NEERGHEEN
Doctor of Philosophy, University of Mauritius
BSc (Honours) Biology with a First Class mention, University of Mauritius
April 2019 to date
§ Associate Professor at the Department of Health Sciences and ANDI Centre of Excellence for
Biomedical and Biomaterials Research, Faculty of Science, University of Mauritius, Réduit, Mauritius.
April 2014 to March 2019
§ Senior lecturer at the Department of Health Sciences and ANDI Centre of Excellence for Biomedical
and Biomaterials Research, Faculty of Science, University of Mauritius, Réduit, Mauritius.
July 2009 to March 2014
§ Lecturer at the Department of Health Sciences and ANDI Centre of Excellence for Biomedical and
Biomaterials Research, Faculty of Science, University of Mauritius, Réduit, Mauritius.
January 2005 to June 2009
§ Education officer at the Ministry of Education and Human Resources, Mauritius.
SELECTED PUBLICATIONS: H-index = 15
Publications in peer-reviewed journals
1) M. Chan Sun, Z. B. Ruhomally, R. Bhoojawon, V. S. Neergheen-Bhujun. Consumption of Moringa
oleifera Lam leaves lowers postprandial blood pressure. Journal of the American College of
Nutrition, 2019, https://doi.org/10.1080/07315724.2019.1608602.
2) N. Rummun, R. E. Hughes, R. Beesoo, W. W. Li, O. Aldulaimi, K. G. Macleod, T. Bahorun2, N. O.
Carragher, A. Kagansky, V. S. Neergheen-Bhujun. Mauritian Endemic Medicinal Plant Extracts
Induce G2/M Phase Cell Cycle Arrest and Growth Inhibition of Oesophageal Squamous Cell
Carcinoma in Vitro. Acta Naturae, 2019,11, 81-90.
3) V. S. Neergheen-Bhujun, Z. B. Ruhomally, R. Bhoojawon, M. Chan Sun. Consumption patterns,
determinants and barriers of the underutilised Moringa oleifera Lam in Mauritius. South African
Journal of Botany, 2019, https://doi.org/10.1016/j.sajb.2019.01.027.
4) N. Rummun, V. S. Neergheen-Bhujun, K. B. Pynee, C. Baider and T. Bahorun. The role of
endemic plants in Mauritian traditional medicine – Potential therapeutic benefits or placebo
effect? Journal of Ethnopharmacology, 2018, 213, 111-117.
5) V. S. Neergheen-Bhujun, A. Taj Awan, Y. Baran, N. Bunnefeld, K. Chan, T. Edison dela Cruz, D.
Egamberdieva S. Elsässer, M. V. Johnson, S. Komai, A. L. Konevega, J. H. Malone, P. Mason,
Vidushi S NEERGHEEN BSc, PhD
12, Remono street,Curepipe Road, MAURITIUS
Office (+230) 403-7400 Ext 4066; Mobile (+230) 5725-9737
• E-mail email@example.com • E-mail firstname.lastname@example.orgR. Nguon, R. Piper, U. B. Shrestha, M. Peši , A. Kagansky. Biodiversity, Drug Discovery, and the
Future of Global Health-introducing the Biodiversity to Biomedicine Consortium, a Call to Action.
2017, 7(2), DOI: doi: 10.7189/jogh.07.020304.
6) P. Ramlagan, P. Rondeau, C. Planesse, V. S. Neergheen-Bhujun, E. Bourdon, T.Bahorun.
Comparative suppressing effects of black and green teas on advanced glycation end products
(AGEs) formation and AGEs-induced oxidative stress. Food and Function, 2017, DOI:
7) R. Beesoo, R. Bhagooli, V. S. Neergheen-Bhujun, W. W. Li, A. Kagansky, T. Bahorun.
Antibacterial and antibiotic potentiating activities of tropical marine sponge extracts. Comparative
Biochemistry and Physiology Part C: Toxicology and Pharmacology, 2017, 196:81-90.
8) P. Ramlagan, P.Rondeau, C. Planesse, V. S. Neergheen-Bhujun, S. Fawdar, E. Bourdon, T.
Bahorun. Punica granatum L. mesocarp suppresses advanced glycation end products (AGEs)-
and H 2 O 2 -induced oxidative stress and pro-inflammatory biomarkers. Journal of functional foods,
2017, 29, 115-126.
9) M. Partolina, H.C. Thoms, K. G. Macleod, G. Rodriguez-Blanco, M. N. Clarke, A. V.
Venkatasubramani, R. Beesoo, V. Larionov, V. S. Neergheen-Bhujun, B. Serrels, H. Kimura, N.
O. Carragher, A. Kagansky. Global histone modification fingerprinting in human cells using
epigenetic reverse phase protein array. Cell Death Discovery, 2017, 3,
10) S. Ramsaha, V.S. Neergheen-Bhujun, S. Verma, A. Kumar, R.K. Bharty, A.K. Chaudhary, P.
Sharma, R.K. Singh, P. Huzar Futty Beejan, K.S. Kang, T. Bahorun. Modulation of
hepatocarcinogenesis in N-methyl-N-nitrosourea treated Balb/c mice by mushroom extracts.
Food and Function, 2016, 7, 594-609.
11) Z. Ruhomally, J. Somanah, T. Bahorun, V.S Neergheen-Bhujun. Morinda citrifolia L. fruit extracts
modulates H 2 O 2 – induced oxidative stress in human liposarcoma SW872 cells. Journal of
Traditional and Complementary Medicine, 2016, 6(3), 299-304.
SCIENTIFIC RESEARCH AND DEVELOPMENT INTERESTS
§ Chemical biology of free radicals and antioxidants in degenerative disorders like cancer, cardiovascular
diseases, diabetes and neurodegeneration.
§ Natural product research and functional food science.
§ Molecular mechanisms of altered signal transduction pathways in disease conditions and how food
biofactors affect the various pathways.
§ Biofactors targeting the multifaceted mechanisms that initiate and promote tumorigenesis
§ Investigating on cell cycle and its various regulators, which will certainly contribute to the understanding
of cancer progression and promotion.
§ Nutraceuticals and functional food development in health and wellness.
ORGANISATIONS/SOCIETIES MEMBERSHIP/EDITORIAL BOARD
§ Next Einstein Forum Fellow (2019-2021)
§ Alumna of the Global Young Academy, The Voice of Young Scientists Around the World. Elected Post
held (1). Executive Committee Member (May 2012-May 2013) and (2). Executive Committee Member
(May 2013- May 2014)
§ Member of Society for Free Radical Research-Africa: Post Held: Secretary
Prof Karl-Heinz WAGNER
Karl-Heinz Wagner is Nutritionist received his PhD 1999 at University of Vienna focusing on lipid oxidation pathways, the evaluation of various bioactive substances and their antioxidative potential. During his Post Doc period, in Vienna and Uppsala (Sweden) he focused on food bioactivity studies and also explored potential anti-genotoxic effects of food compounds. Since 2011 he is Full Prof. at University of Vienna, Faculty of Life Sciences and he is co-leading the faculty focus “Nutrition and Ageing” and leading the Emerging Field “Oxidative Stress and DNA Stability”. The latter field is now the main research focus which is explored in several international human intervention studies trying to predict the risk of chronic diseases such as cancer and CVD on systemic, cellular and molecular level. Since 2010 he is Adjunct Professor at Griffith University in Australia and in this year he also received the leadership of the University Research Platform “Active Ageing”, which is still successfully ongoing. His research is mainly biomarker driven and following a translational approach from cell to organism. With the research platform he has performed several national and international intervention studies in the elderly population focusing thereby on the diet, specific nutrients and physical activity. One research field in the biomedical area he is exploring sine one decade is bilirubin metabolism and its associations to chronic diseases. Very recently, he has started to link bilirubin metabolism to large epidemiological consortia in order to explore this field with new epidemiological tools such as Mendelian randomization. He is working in an international environment with collaboration partners across all continents. He is Vice-Dean of the Faculty of Life Sciences, President of the Austrian Nutrition Society and serves in the Austrian Nutrition Commission and the Scientific advisory board of the German Nutrition Society.
Dr. Wagner has published more than 200 papers in ISI journals and is author of more than 25 book chapter. He also served as guest editor for numerous special issues in peer-reviewed scientific journals and edited 2 books.